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Abstract Ocular tuberculosis is difficult to diagnose
but should be suspected when uveitis fails to respond to
inflammation suppressive therapy. Interferon-gamma
release assays (IGRAs) represent a substantial help to
diagnose suspected ocular tuberculosis especially in
non-endemic areas. Indocyanine green angiography
(ICGA) is able to detect clinically silent choroiditis
that, when associated with a positive IGRA test, should
lead the clinician to suspect ocular tuberculosis,
warranting specific therapy. The fact that IGRA tests
can also react with some atypical strains of mycobac-
teria is not always known. We report here a case with
resistant post-operative inflammation that presented
with occult ICGA-detected choroiditis and a positive
IGRA test that was most probably due to the non-
tuberculous mycobacterium (NTM) Mycobacterium
kansasii. A 66 year-old man presented with a resistant
cystoid macular oedema (CMO) in his left eye after
combined cataract and epiretinal membrane surgery.
At entry, his best-corrected visual acuity (BCVA) was
0.5 for far and near OS. Intraocular inflammation
measured by laser flare photometry was elevated
in the left eye (54.4 ph/ms) and also in the right eye
(50.9 ph/ms). Four subTenon’s injections of 40 mg of
triamcinolone did not produce any substantial
improvement. Therefore a complete uveitis work-up
was performed. Fluorescein angiography showed
CMO OS and ICGA showed numerous hypofluores-
cent dots and fuzziness of choroidal vessels in both
eyes. Among performed laboratory tests, the Quanti-
FERON-TB Gold test was positive. After a pulmo-
nological examination disclosing a right upper lobe
infiltrate, the patient was started on a triple anti-
tuberculous therapy. Bronchial aspirate, obtained dur-
ing bronchoscopy, was Ziehl-positive and culture grew
M. kansasii. Nine months later, BCVA OS increased to
1.0 and flare decreased to 40.2 ph/ms. The CMO OS
resolved angiographically and did not recur with a
macula still slightly thickened on OCT. Suspected
ocular tuberculosis based on clinical findings and a
positive IGRA test can, in rare instances, be due to
atypical mycobacteria that also produce positive IGRA
tests such as M. kansasii, M. szulgai, M. gordonae,
M. flavescens and M. marinum. In our case failure to
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isolate the atypical mycobacterium would not have had
negative therapeutic consequences, as M. kansasii is
sensitive to the standard anti-tuberculous treatments,
which is not the case with other NTMs.
Keywords Atypical mycobacteria  Mycobacterium
kansasii  Choroiditis  Uveitis  Presumed ocular
tuberculosis  IGRA tests  Indocyanine green
angiography
Introduction
Ocular tuberculosis in non-endemic areas is usually
more discreet and diagnosis is more difficult than in
endemic areas. Moreover, unlike in endemic areas,
polymerase chain reaction (PCR) identification of
Mycobacterium tuberculosis DNA in ocular fluids is
often negative. The choroid is frequently involved in
ocular tuberculosis [1] but choroiditis can sometimes be
very faint. The most sensitive method to explore and
monitor the inflammatory involvement of the choroid is
indocyanine green angiography (ICGA) often detecting
subclinical choroidal inflammation [2]. For example,
subclinical presumed tuberculous choroiditis was
detected using ICGA in a patient presenting with
isolated papillitis and responded to anti-tuberculous
therapy alone [3]. ICGA was also the most useful
method to follow interferon-gamma release assay
(IGRA)-positive multifocal-serpiginous choroiditis [4].
Significant clinical evidence indicates that IGRAs
are more specific than the purified protein derivative
(PPD) skin tests in diagnosing tuberculosis as it is not
confounded by prior bacillus Calmette-Gue´rin (BCG)
vaccination and one of the two tests also being
significantly more sensitive than the PPD skin test [5].
QuantiFERON-TB Gold (Cellestis; Carnegie, Aus-
tralia) is one of the IGRA tests using a whole-blood
enzyme-linked immunosorbent assay, which measures
the release of interferon gamma (IFN-c) in response to
three allegedly M. tuberculosis complex-specific pro-
teins (M. tuberculosis, M. africanum, M. bovis). The
detection and quantification of IFN-c released by T
cells in response to ESAT-6, CFP-10 and TB7.7 (p4)
proteins is the basis of this test. These proteins are
absent from BCG strain and from most non-tubercu-
lous mycobacteria (NTM) with the exception of
M. kansasii, M. szulgai, M. marinum, M. gordonae,
M. flavescens, and M. gastri [6, 7]. Ingen et al. [8],
however, were unable to demonstrate that genes
encoding ESAT-6 and CFP-10 are present in
M. flavescens, but revealed it in M. riyadhense.
Consequently, a positive result of the IGRA test is a
support for diagnosing tuberculous uveitis, but can
also indicate diseases caused by a few other myco-
bacteria (Table 1). Therefore disease caused by some
NTMs cannot be excluded by this test. Although
NTMs are rare causative agents of ocular infections,
NTMs produced sporadic cases of keratitis, scleritis,
endophthalmitis, orbital granuloma and chorioretinitis
[9–12]. M. riyadhense and M. gastri, however, have
not yet been shown to cause ocular infections.
It is commonly accepted that the combination of a
positive IGRA test and a compatible clinical picture
indicates ocular tuberculosis until proven otherwise
and specific therapy should be applied [3, 4, 13, 14].
We present a case with resistant post-surgical
inflammation presenting cystoid macular oedema
(CMO) in one eye as well as bilateral occult, ICGA-
detected choroiditis associated with a positive IGRA
test where culture was finally positive for M. kansasii
and which responded to standard anti-tuberculous
therapy.
Case report
A 66 year-old male patient had undergone surgery for
a combined cataract and epiretinal membrane (ERM)
in his left eye one year prior to being seen in our
centre. Vision recovered to 1.0 after the operation;
however, 4 months later vision decreased again to 0.6
OS and a CMO was seen on fluorescein angiography
(FA) and optical coherence tomography (OCT; Hei-
delberg Engineering, Inc., Heidelberg, Germany). An
intraocular injection of 4 mg of triamcinolone was
performed with an improvement of the OCT scans but
a stagnation of visual acuity around 0.5 and an
increase of intraocular pressure to 32 mmHg.
He was referred to the Centre for Ophthalmic
Specialised care (COS), Lausanne, Switzerland, for a
resistant post-operative CMO at the end of February
2011. At entry, his treatment for the left eye included
Azopt BID, prednisolone acetate 1 % drops BID,
indomethacin 0.1 % drops 69 daily and Diamox
375 mg/day. The best-corrected visual acuity was 1.25
for far and 1.0 for near OD and 0.5 for far and near OS.
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Intraocular pressures were 22 and 28 mmHg, respec-
tively, for the left and right eyes. Intraocular inflam-
mation measured by laser flare photometry (LFP) was
elevated on the left with a value of 54.4 ph/ms (normal
values, 3–6 ph/ms). Surprisingly, his right eye also
had an elevated flare with a value of 50.9 ph/ms.
A CMO was seen in the left eye and confirmed by OCT
(Fig. 1). Visual field testing using Octopus (Haag-
Streit, Bern, Switzerland) showed no significant visual
field impairment on either side and microperimetry
displayed a mild diminished retinal sensitivity in the
left eye with a test score of 364/560 versus 460/560
OD.
As the case was considered a resistant post-
operative CMO no uveitis work-up was performed at
initial presentation. Four subTenon’s injections of
40 mg of triamcinolone were performed on the left
side at 3–4 week intervals. Four months later the
situation had not changed substantially on the left with
a BCVA of 0.6, intraocular pressure of 14 mmHg,
inflammation remaining at 52.1 ph/ms and a CMO
quasi identical on OCT to the situation at entry
(Fig. 1).
Therefore a complete uveitis work-up was per-
formed with the following findings. FA showed CMO
on the left and disc hyperfluorescence OU (Fig. 2).
ICGA indicated hypofluorescent dots and fuzziness
of choroidal vessels in both eyes (Fig. 3). Among
performed laboratory examinations, the QuantiFER-
ON-TB Gold test was positive suggesting sensitisat-
ion to the M. tuberculosis complex. When this result
was given to the patient he recalled having been
treated for tuberculosis as a youngster.
Prior to the initiation of a specific treatment, a chest
X-ray was performed since the patient had been
treated a few months earlier by amoxicillin/clavulanic
acid for a right upper lobe pneumonia with nocturnal
sweats and a loss of 5 kg. An infiltrate in the right
Table 1 Cross-reactivity in IGRA tests
Tuberculosis complex ESAT-6 CFP-10 TB7.7a Environmental strains ESAT-6 CFP-10 TB7.7a
M. tuberculosis ? ? ? M. abcessus - - -
M. africanum ? ? ? M. avium - - -
M. bovis ? ? ? M. gordonii ? ? ?
BCG substrain M. kansasii ? ? ?
Gothenburg - - - M. szulgai ? ? ?
Moreau - - - M. marinum ? ? ?
Tice - - - M. gastri ? ? ?
Tokyo - - - M. flavescens ± ± ±
Danish - - - M. riyadhense ± ± ±
Glaxo - - - M. fortuitum - - -
Montreal - - - M. branderi - - -
Pasteur - - - M. intracellulare - - -
M. malmoense - - -
M. scrofulaceum - - -
M. smegmatis - - -
M. terrae - - -
M. vaccae - - -
M. xenopi - - -
M. oenavense - - -
M. celatum - - -
M. chelonae - - -
Table shows significant cross-reactivity between Mycobacteria tuberculosis complex and environmental strains such as M. kansasii,
M. szulgai, M. marinum, M. gordonae, M. flavescens, M. gastri, M. flavescens and M. riyadhense (modified from Quest Diagnostics
Incorporated and Biomerieux)
a QuantiFERON only
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upper lobe was still present. Smears of bronchial
aspirate obtained during a flexible bronchoscopy
disclosed 1–10 acid-fast bacilli/field but PCR for M.
tuberculosis was negative. The patient was then
started on a triple anti-tuberculous therapy including
isoniazid, rifampicin and ethambutol. Surprisingly,
the bronchial aspirate culture came back positive for
M. kansasii, which is susceptible to classical anti-
tuberculous treatment. The therapy was therefore
continued.
Five months later, BCVA was 1.25 OD and
increased to 0.9 OS. Intraocular pressure was normal
at 14 mmHg OU. Inflammation measured by LFP still
amounted to 35.1 ph/ms OD and had improved to
42.8 ph/ms OS. The CMO improved markedly on
OCT for the first time (Fig. 4).
FA was within normal limits on both sides and there
were neither hypofluorescent spots nor fuzziness of
choroidal vessels seen on ICGA any more. At no time
during nine months of follow-up did the CMO recur
Fig. 1 OCTs of right and left maculas at presentation (top two
pictures) and after four sub-Tenon’s triamcinolone injections
OS (two bottom pictures). Extensive cystoid macular oedema
seen OS at presentation (top right picture) and quasi identical
cystoid macular oedema after four subTenon’s triamcinolone
injections (bottom right)
Fig. 2 FA showing cystoid
macular oedema in the left
eye (bottom pictures)
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and BCVA improved in the left eye to 1.0 with a
decrease of flare to 40.2 ph/ms.
Discussion
When intraocular inflammation is not responding to
adequate inflammation suppressive therapy (IST), an
infectious cause should be suspected. The patient
presented here was first treated as a common post-
surgical inflammation in his left eye after a combined
cataract and ERM operation but was resistant to both
one intraocular and repeated sub-Tenon’s injections of
triamcinolone. Since a complete uveitis work-up
showed occult choroiditis on ICGA as well as a
positive IGRA test, the diagnosis of presumed ocular
tuberculosis was made. A classical triple anti-tuber-
culous therapy was initiated following flexible bron-
choscopy performed because of a persistent upper
right lobe infiltrate.
IGRA tests are very helpful, especially in non-
endemic areas, to orient the diagnosis of IST-resistant
uveitis cases towards possible ocular tuberculosis in
case of IGRA positivity with a compatible clinical
presentation. In such a situation the patient should be
considered to have ocular tuberculosis until proven
otherwise and specific treatment is warranted [3, 4, 13,
14]. However, it is not well known that IGRA tests are
in fact not only identifying M. tuberculosis complex
but also at least five NTMs including M. kansasii,
M. szulgai, M. marinum, M. gordonae and M. flaves-
cens that can cause ocular infections [6, 7]. This is
indicated in Table 1 showing significant cross-reac-
tivity between M. tuberculosis complex and environ-
mental strains such as M. kansasii, M. szulgai,
M. marinum, M. gordonae, M. flavescens, M. gastri,
M. flavescens and M. riyadhense (Table 1).
After having started anti-tuberculous therapy in
our patient, a bronchial aspirate culture yielded the
NTM M. kansasii. Non-tuberculosis mycobacteria are
Fig. 3 ICGA showing hypofluorescent dark dots OU and fuzziness of choroidal vessels (OD left figure, OS right figure)
Fig. 4 OCTs of right and left maculas showing resolution of CMO OS after anti-tuberculous therapy; the left macula still showing an
increased thickness (right picture)
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subdivided into three groups of slow-growing strains
(SGMs) where M. kansasii, M. marinum, M. szulgai
and M. gordonae are included and one group of rapidly
growing strains [15]. Ocular infections are mostly
caused by M. abcessus and M. chelonae, a rapidly
growing mycobacteria (RGM), which is mostly
involved in keratitis reports [16–18] and which does
not produce a positive IGRA test [19]. Moreover,
tuberculosis-like chorioretinitis has also been reported
in association with a non-characterised RGM [9].
Grenzebach et al. [11] have reported a case of
granulomatous tuberculous-like endophthalmitis
caused by an atypical rapidly growing mycobacterium
strain. In a case of scleritis, Tanemoto et al. [12] were
able to identify an atypical mycobacterium by PCR in
eye discharge and gastric juices while culture and
microscopy were negative.
Although very rare, all five SGM NTMs cited above
that produce a positive IGRA test have been reported
to cause intraocular inflammation. Table 2 shows non-
tuberculous mycobacteria which cause different
ocular diseases together with their IGRA cross-
reactivity characteristics and type of growth. Lai
et al. [10] reported a case of systemic dissemination of
M. kansasii including tuberculosis-like chorioretinitis
and cytomegalovirus retinitis in a patient with
acquired immune deficiency syndrome. Other cases
of non-ocular infections by M. kansasii in immuno-
suppressed as well as in immunocompetent patients
have been described [20, 21]. One case of keratitis,
one case of sclerokeratitis and one case of preseptal
cellulitis due to M. marinum [22–24], one case of
keratouveitis and two cases of post-LASIK keratitis
due to M. szulgai have been reported in the literature
[16, 25]. M. gordonae was also shown to cause
keratitis and was isolated by culture [26, 27].
Bullington et al. [28] published a case of M. flavescens
keratitis and confirmed that cultures and sensitivity
tests are mandatory in determining appropriate
treatment.
Fortunately, there are no negative therapeutic
consequences in case of M. kansasii infections mis-
diagnosed as M. tuberculosis following a positive
IGRA test, as this strain is usually sensitive to standard
anti-tuberculous therapy [21, 29]; however, the
recommended duration of treatment is 18 months
[30, 31]. In contrast, if infections due to M. szulgai,
M. gordonae, M. flavescens or M. marinum are
misdiagnosed as tuberculosis due to a positive IGRA
test, this can have deleterious therapeutic conse-
quences as these SGM NTMs are resistant to standard
anti-tuberculous therapy [32, 33]. The combination of
trimethoprime/sulfametoxazole and doxycycline has
been suggested for infections due to M. szulgai and





which cause different ocular
diseases, as well as IGRA
cross-reactivity











Type of ocular disease
M. abcessus - RGM Keratitis [37], endophthalmitis
[39, 40]
M. asiaticum - SGM Keratitis [41]
M. avium-intracellulare - SGM Keratitis [41], corneal ulcer [42]
M. chelonae - RGM Keratitis [16, 41], orbital
granuloma [44],
endophthalmitis [38, 40]
M. flavescens ± SGM Keratitis [28]
M. fortuitum - RGM Keratitis [41], cornea ulcer [43]
M. gordonae ? SGM Keratitis [26, 27]
M. kansasii ? SGM Chorioretinitis [10]
M. marinum ? SGM Keratitis [23], sclerokeratittis [22],
preseptal
cellulitis [24]
M. nonchromogenicum - SGM Keratitis [41]
M. szulgai ? SGM Keratitis [16], keratouveitis [25]
M. trivial - SGM Keratitis [41]
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M. marinum [34]. M. gordonae was reported to be
sensitive to azithromycin, rifampin and quinolones
[35, 36]. In the present case, the clinical response after
nine months of therapy has been spectacular with no
recurrence so far.
In conclusion, if ocular clinical findings are com-
patible with a tuberculous uveitis in presence of a
positive IGRA test, ocular tuberculosis should be
strongly suspected and a therapeutic trial is warranted.
As IGRA tests do not react with most of the NTMs,
they do react with M. kansasii, M.szulgai, M. gordo-
nae, M. flavescens and M. marinum and an IGRA test
cannot exclude an infection by these agents. Although
this is a very rare occurrence, it deserves to be known
for potential cases resistant to standard anti-tubercu-
lous therapy. In the reported case we strongly suspect
that the same organism as the one found in the lung
was causing the ocular disease. Fortunately, the
consequences would not have been deleterious,
unlike for M. szulgai, M. gordonae, M. flavescens or
M. marinum, if the organism had not been isolated in
the lung as both M. tuberculosis and M. kansasii are
sensitive to the same drugs.
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